cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ginkgo Bioworks Holdings Inc
58 own
57 watching
Current Price
$8.56
$-0.3
(-3.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
351.24M
52-Week High
52-Week High
64.40000
52-Week Low
52-Week Low
5.26000
Average Volume
Average Volume
2.2M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization351.24M
icon52-Week High64.40000
icon52-Week Low5.26000
iconAverage Volume2.2M
iconDividend Yield--
iconP/E Ratio--
What does the Ginkgo Bioworks Holdings Inc do?
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It also focuses on the design of next-generation cell therapies for autoimmune diseases. It uses its platform to develop and screen libraries of novel NK-specific and T-cell specific chimeric antigen receptor and switch receptor designs, which enable control and performance of immune cell-based therapies.
Read More
How much money does Ginkgo Bioworks Holdings Inc make?
News & Events about Ginkgo Bioworks Holdings Inc.
PR Newswire
1 year ago
Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer PR Newswire BOSTON, May 5, 2023 Mr. Coen brings over 30 years of public accounting and corporate finance leadership experience...
PR Newswire
1 year ago
Cambrium and Ginkgo Bioworks Complete Successful Collaboration on Data-Driven Cell Factory Engineering Cambrium and Ginkgo Bioworks Complete Successful Collaboration on Data-Driven Cell Factory Engineering PR Newswire BERLIN and BOSTON, April 18, 2023 BERLIN and BOSTON, April 18, 2023 /PRNewswire...
Ticker Report
1 year ago
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA Get Rating) insider Reshma P. Shetty sold 37,650 shares of Ginkgo Bioworks stock in a transaction that occurred on Wednesday, April 12th. The stock was sold at an average price of $1.31, for a total value of $49,321.50. Following the transaction, the ...
PR Newswire
1 year ago
Ginkgo Bioworks and the Government of the Democratic Republic of the Congo Announce Plans to Develop and Implement New Biosecurity Capabilities in the Region Ginkgo Bioworks and the Government of the Democratic Republic of the Congo Announce Plans to Develop and Implement New Biosecurity...
PR Newswire
1 year ago
Ginkgo Bioworks to Host Annual Ferment Conference Ginkgo Bioworks to Host Annual Ferment Conference PR Newswire BOSTON, April 12, 2023 BOSTON, April 12, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its...
Frequently Asked Questions
Frequently Asked Questions
What is Ginkgo Bioworks Holdings Inc share price today?
plus_minus_icon
Can Indians buy Ginkgo Bioworks Holdings Inc shares?
plus_minus_icon
How can I buy Ginkgo Bioworks Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Ginkgo Bioworks Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ginkgo Bioworks Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Ginkgo Bioworks Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Ginkgo Bioworks Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ginkgo Bioworks Holdings Inc?
plus_minus_icon
What percentage is Ginkgo Bioworks Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ginkgo Bioworks Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.56
$-0.3
(-3.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00